The 20 Best Graft Versus Host Disease (GvHD) Doctors Near Me in Rochester, NY

Sergio Giralt is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Giralt is rated as an Elite provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Graft Versus Host Disease (GvHD), Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Splenectomy. Dr. Giralt is currently accepting new patients.

Benedetto Bruno is a Hematologist practicing medicine in New York, New York. Dr. Bruno is rated as an Elite provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Multiple Myeloma, Leukemia, Acute Myeloid Leukemia (AML), and Bone Marrow Transplant.

Doris Ponce is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Ponce is rated as an Elite provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Graft Versus Host Disease (GvHD), Myelodysplastic Syndrome (MDS), Leukemia, Bone Marrow Transplant, and Splenectomy. Dr. Ponce is currently accepting new patients.

Ran Reshef is a Transplant Surgeon practicing medicine in New York, New York. Dr. Reshef is rated as an Elite provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Multiple Myeloma, Non-Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Reshef is currently accepting new patients.

James Ferrara is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Ferrara is rated as an Elite provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Smoldering Multiple Myeloma, Immune Thrombocytopenic Purpura (ITP), and Bone Marrow Transplant.

Roni Tamari is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Tamari is rated as an Elite provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). She is also highly rated in 23 other conditions, according to our data. Her clinical expertise encompasses Myelodysplastic Syndrome (MDS), Myelofibrosis, Graft Versus Host Disease (GvHD), Bone Marrow Transplant, and Bone Graft. Dr. Tamari is currently accepting new patients.

Alina Markova is a Dermatologist practicing medicine in New York, New York. Dr. Markova is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Graft Versus Host Disease (GvHD), Acute Febrile Neutrophilic Dermatosis, Mycosis Fungoides, and T-Cell Lymphoma.

Ann Jakubowski is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Jakubowski is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Graft Versus Host Disease (GvHD), Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Bone Graft. Dr. Jakubowski is currently accepting new patients.

Jane Liesveld is a Hematologist practicing medicine in Rochester, New York. Dr. Liesveld is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). She is also highly rated in 42 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration.

Mitchell Cairo is a Pediatrics provider practicing medicine in Hawthorne, New York. Dr. Cairo is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Burkitt Lymphoma, Primary Mediastinal B-Cell Lymphoma (PMBCL), B-Cell Lymphoma, Non-Hodgkin Lymphoma, and Bone Marrow Transplant.

"Monica Bhatia, MD specializes in the care of children with noncancerous blood disorders who may benefit from bone marrow transplantation, especially sickle cell anemia. She and her colleagues are working to reduce the toxicity (side effects) and complications of this treatment without compromising its effectiveness, and to make it available to more patients. The field of pediatric hematology brings with it many intellectual challenges, and bone marrow transplantation in particular is especially dynamic. Dr. Bhatia has the opportunity to provide care for the sickest children, potentially curing their disease. She builds strong relationships with her patients and their families that last for years. It is inspiring for her to see young patients grow up to lead healthy, productive lives. NewYork-Presbyterian/Morgan Stanley Children's Hospital has a robust program for bone marrow transplantation for sickle cell anemia - the only cure for this disease. Dr. Bhatia and her team have witnessed remarkable results among children who are cured with bone marrow transplantation and spared from the potentially life-threatening complications of sickle cell disease. Yet despite the advances made, only 15 percent of patients with sickle cell disease have a matched sibling bone marrow donor. Therefore, Dr. Bhatia and her team conduct research to evaluate a procedure called ""CD34-selected stem cell transplantation"" to remove T-cells from donor bone marrow for patients without a matched sibling donor. This approach reduces the risk of graft-versus-host disease (GVHD), a potential complication of bone marrow transplantation in which T-cells from the donor attack the tissue of the recipient. This approach to harnessing stem cells could potentially make bone marrow transplantation a safer, effective option for many patients who are seeking a cure for sickle cell disease. Dr. Bhatia and her colleagues are currently assessing reduced-intensity transplantation, which uses lower doses of chemotherapy to decrease the risk of side effects and long-term complications without lowering the effectiveness of treatment. She is also interested in looking for ways to further improve the quality of life of patients who have had a bone marrow transplant in addition to fertility preservation.". Dr. Bhatia is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, Hemolytic Anemia, and Bone Marrow Transplant. Dr. Bhatia is board certified in Pediatrics and Pediatric Hematology-Oncology. Dr. Bhatia is currently accepting new patients.

Prakash Satwani, MD specializes in the use of bone marrow transplantation to treat children and adolescents with leukemia, lymphoma, or hemophagocytic lymphohistiocytosis. Bone marrow transplantation is a dynamic, intriguing field with multiple complex issues. Dr. Satwani has always enjoyed solving puzzles and is attracted to the intellectual challenge of caring for patients whose lives may be saved or extended with bone marrow transplantation. Dr. Satwani is also inspired and motivated by the long-lasting and rich relationships formed with patients and their families, and often keeps in touch with families long after their child's treatment has been completed. Dr. Satwani teaches medical students, residents, fellows, nurses, and nurse practitioners about bone marrow transplantation. It's important to educate people so they can learn the latest advances and provide the best care possible for patients. To continue to achieve those advances, Dr. Satwani conducts clinical research in reducing the life-threatening complications related to transplantation, such as infections and graft-versus-host disease. Dr. Satwani and colleagues also evaluate reduced-intensity bone marrow transplantation preparative regimens, which use lower doses of chemotherapy with the hope of decreasing short-term and long-term complications without compromising the effectiveness of treatment. Dr. Satwani is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Anemia, Hemophagocytic Lymphohistiocytosis, Sickle Cell Disease, and Bone Marrow Transplant. Dr. Satwani is board certified in Pediatric Hematology-Oncology. Dr. Satwani is currently accepting new patients.

An internationally known leader in hematology, A. Samer Al-Homsi, MD, MBA, is system chief of blood and marrow transplant and cellular therapy at the Northwell Health Cancer Institute, where he also serves as director of faculty and academic affairs in medical oncology.In his position, Dr. Al-Homsi treats patients in need of blood and marrow transplantation for blood cancers and other blood conditions. Dr. Al-Homsi attended medical school at Damascus University Faculty of Medicine, did his residency at Advocate Christ Medical Center in Illinois, and completed a fellowship at UMass Chan Medical School in Worcester, MA. He also received training and practiced in France. He came to Northwell from the Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, where he was executive director of transplantation and cellular therapy. His research efforts throughout his career have focused on innovations that lead to better patient care in blood and marrow transplantation.The poet Kahlil Gibran wrote that work is love made visible, and I believe medicine is love made visible, says Dr. Al-Homsi. Every patient has unique needs, based not just on their specific condition, but also on their cultural background, family situation, and the impact of their disease. We're fortunate at Northwell to have care delivered by a large team that's there to address all those aspects.Dr. Al-Homsi is looking forward to advancing more clinical research at Northwell's Feinstein Institutes for Medical Research and at Cold Spring Harbor Laboratory. That will likely facilitate the development of more therapies that can treat patients, he says, and in a way that's safer and more effective.Dr. Al-Homsi doesn't just focus on the physical effects of conditions like leukemia, lymphoma, and multiple myeloma with decades of patient care, he also knows the tremendous value of a deeper conversation about how cancer is affecting patients mental health and everyday function. His priority is to learn about the patient first and the disease second.That perspective on patient advocacy and approaching each interaction with compassion and love is the same now as it was when he first entered medical school, he recalls. I wanted my life to matter, and to make a difference, he says. I'm not trying to change the world, but I can change patients' lives. I can change their world, and that's incredibly rewarding and meaningful. Dr. Al is rated as an Advanced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Multiple Myeloma, Chronic T-Cell Leukemia (CTCL), Adult T-Cell Leukemia, and Bone Marrow Transplant. Dr. Al is board certified in American Board Of Internal Medicine/Hematology.

Ruthee-lu Bayer is a Transplant Surgeon practicing medicine in Lake Success, New York. Dr. Bayer is rated as an Advanced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Bayer is board certified in American Board Of Internal Medicine.

Dr. Mina Aziz is a dermatologist who diagnoses and treats diseases of the skin and performs cosmetic procedures. Dr. Aziz is rated as an Advanced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD) and Lymphomatoid Papulosis. Dr. Aziz is board certified in American Board Of Internal Medicine.

Marina Konopleva, MD, Phd, is Professor, Oncology, Professor, Molecular Pharmacology, Director, Leukemia Program and Co-Director, Blood Cancer Institute, at Montefiore Einstein. Her clinic focus centers on treating patients with hematologic malignancies, with an emphasis on acute myeloid and acute lymphoblastic leukemia. She has additional expertise in treating patients with high-risk myelodysplastic syndrome and chronic myeloid leukemia. Dr. Konopleva is rated as an Advanced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). She is also highly rated in 26 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant.

Esperanza Papadopoulos is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Papadopoulos is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Graft Versus Host Disease (GvHD), Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Colonoscopy. Dr. Papadopoulos is currently accepting new patients.

Brian Shaffer is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Shaffer is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Bone Graft. Dr. Shaffer is currently accepting new patients.

Hugo Castro is a Hematologist practicing medicine in New York, New York. Dr. Castro is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Myelodysplastic Syndrome (MDS), Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), Aplastic Anemia, and Bone Marrow Transplant.

Jaap-jan Boelens is a Transplant Surgeon practicing medicine in New York, New York. Dr. Boelens is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Metachromatic Leukodystrophy, Leukodystrophy, Hepatic Venoocclusive Disease with Immunodeficiency, and Bone Marrow Transplant. Dr. Boelens is currently accepting new patients.